A Comparison of Single-Dose Cefixime with Ceftriaxone as Treatment for Uncomplicated Gonorrhea

New England Journal of Medicine

Volumn 325, Issue 19, 1991, Pages 1337-1341

  Handsfield, H Hunter ^a   McCormack, William M ^b   Hook, Edward W ^c   Douglas, John M ^d   Covino, Jean M ^b   Verdon, Michael S ^a   Reichart, Cindy A ^c   Ehret, Josephine M ^d   Siegal, Nancy A ^e   Smith, Barry ^e   Cummings, Marinella C ^e   Hutchinson, Catherine ^e   Goldberg, Mindy ^e   Schempf, Ann M ^e  

^a UNIVERSITY OF WASHINGTON   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d Denver Disease Control Service   (United States)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CEFIXIME; CEFTRIAXONE; LIDOCAINE; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; CHLAMYDIASIS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; DRUG TOLERANCE; FEMALE; GONORRHEA; HUMAN; INJECTION PAIN; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 0026008678     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199111073251903     Document Type: Article

References (30)

1. Schwarcz S.K., Zenilman J.M., Schnell D., et al. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. JAMA 1990; 264:1413-1417
2. Plasmid-mediated antimicrobial resistance in Neisseria gonorrhoeae —United States, 1988 and 1989. MMWR 1990; 39:284-7, 293.
3. 1989 Sexually transmitted diseases treatment guidelines. MMWR 1989; 38(S-8):21-23
4. Stone J.W., Linong G., Andrews J.M., Wise R. Cefixime, in-vitro activity, pharmacokinetics, and tissue penetration. J Antimicrob Chemother 1989; 23:221-228
5. Bowie W.R., Shaw C.E., Chan D.G., Boyd J., Black W.A. In vitro activity of diffoxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens. Antimicrob Agents Chemother 1986; 30:590-593
6. Brittain D.C., Scully B.E., Hirose T., Neu H.C. The pharmacokinetic and bactericidal characteristics of oral cefixime. Clin Pharmacol Ther 1985; 38:590-594
7. Guay D.R.P., Meatherall R.C., Harding G.K., Brown G.R. Pharmacokinetics of cefixime (CL 284,635; FK 027) in healthy subjects and patients with renal insufficiency. Antimicrob Agents Chemother 1986; 30:485-490
8. Kuhlwein A., Nies B.A. Efficacy and safety of a single 400 mg oral dose of cefixime in the treatment of uncomplicated gonorrhea. Eur J Clin Microbiol Infect Dis 1989; 8:261-262
9. Megran D.W., Lefebvre K., Willetts V., Bowie W.R. Single-dose oral cefixime versus amoxicillin plus probenecid for the treatment of uncomplicated gonorrhea in men. Antimicrob Agents Chemother 1990; 34:355-357
10. Schoenknecht F.D., Sabath L.D., Thornsberry C. Susceptibility tests: special tests. In: Lennette EH, Balows A, Hauser WJ Jr, Shadomy HJ, eds. Manual of clinical microbiology. 4th ed. Washington, D.C.: American Society for Microbiology, 1985: 1000-8.
11. Handsfield H.H., Sandström E.G., Knapp J.S., et al. Epidemiology of penicillinase-producing Neisseria gonorrhoeae infections: analysis by auxotyping and serogrouping. N Engl J Med 1982; 306:950-954
12. Knapp J.S., Tam M.R., Nowinski R.C., Holmes K.K., Sandström E.G. Serologic classification of Neisseria gonorrhoeae with use of monoclonal antibodies to gonococcal outer membrane protein. J Infect Dis 1984; 150:44-48
13. Jaffe H.W., Schroeter A.L., Reynolds G.H., Zaidi A.A., Martin J.E. Jr., Thayer J.D. Pharmacokinetic determinants of penicillin cure of gonococcal urethritis. Antimicrob Agents Chemother 1979; 15:587-591
14. Moran J.S., Zenilman J.M. Therapy for gonococcal infections: options in 1989. Rev Infect Dis 1990; 12:Suppl 6:S633-S644.
15. Rice R.J., Thompson S.E. Treatment of uncomplicated infections due to Neisseria gonorrhoeae: a review of clinical efficacy and in vitro susceptibility studies from 1982 through 1985. JAMA 1986; 255:1739-1746
16. Veller-Fornasa C., Tarantello M., Cipriani R., Guerra L., Peserico A. Effect of ofloxacin on Treponema pallidum in incubating experimental syphilis. Genitourin Med 1987; 63:214.
17. Christ W., Lehnert T., Ulbrich B. Specific toxicologic aspects of the quinolones. Rev Infect Dis 1988; 10:Suppl 1:S141-S146.
18. Wolfson J.S., Hooper D.C. Bacterial resistance to quinolones: mechanisms and clinical importance. Rev Infect Dis 1989; 11:Suppl 5:S960-S968.
19. Wagenvoort J.H., van der Willigen A.H., van Noort J.A. Decreased sensitivity of Neisseria gonorrhoeae to quinolone compounds. Eur J Clin Microbiol 1986; 5:685.
20. Joyce M.P., Aying B.B., Vaughan G.H., et al. In vitro sensitivity of Neisseria gonorrhoeae to quinolone antibiotics in the Republic of the Philippines. Presented at the Sixth International Pathogenic Neisseria Conference, Pine Mountain, Ga. October 16–21, 1988. abstract.
21. Yeung K.H., Dillon J.R. Norfloxacin resistant Neisseria gonorrhoeae in North America. Lancet 1990; 336:759.
22. Jephcott A.E., Turner A. Ciprofloxacin resistance in gonococci. Lancet 1990; 335:165.
23. Sparling P.F. Biology of Neisseria gonorrhoeae. In: Holmes KK, Mårdh P-A, Sparling PF, et al. eds. Sexually transmitted diseases. 2nd ed. New York: McGraw-Hill, 1990: 131-47.
24. Ison C.A., Bindayna K.M., Woodford N., Gill M.J., Easmon C.S.F. Penicillin and cephalosporin resistance in gonococci. Genitourin Med 1990; 66:351-356
25. Handsfield H.H., Hook E.W. III. Ceftriaxone for treatment of uncomplicated gonorrhea: routine use of a single 125-mg dose in a sexually transmitted disease clinic. Sex Transm Dis 1987; 14:227-230
26. Jacoby G.A., Medeiros A.A. More extended-spectrum β-lactamases. Antimicrob Agents Chemother 1991; 35:1697-1704
27. Drug topics red book 1991. Oradell, N.J.: Medical Economics, 1991.
28. Baddour L.M., Gibbs R.S., Mertz G., Cocchetto D.M., Noble R.C. Clinical comparison of single-oral-dose cefuroxime axetil and amoxicillin with probenecid for uncomplicated gonococcal infections in women. Antimicrob Agents Chemother 1989; 33:801-804
29. Steingrimsson O., Olafsson J.H., Thorarinsson H., Ryan R.W., Johnson R.B., Tilton R.C. Azithromycin in the treatment of sexually transmitted disease. J Antimicrob Chemother 1990; 25:Suppl A: 109-14.
30. Martin D.H., Mroczkowski T.F., Dalou Z.A., et al. A multicenter, randomized trial of single dose azithromycin (A) vs. multidose doxycycline (D) for Chlamydia trachomatis (Ct) genital tract infection. In: Program and abstracts of the 31st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, September 29-October 2, 1991. Washington, D.C.: American Society for Microbiology, 1991:III. abstract.